Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible TuberculosisPayam Nahid, Andrew Vernon, Susan E. Dorman et al.|Clinical Infectious Diseases|2016Cited by 1.5k
Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guidelineCharles L. Daley, Kevin Winthrop|European Respiratory Journal|2020Cited by 876
Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice GuidelineCharles L. Daley, Kevin Winthrop|Clinical Infectious Diseases|2020Cited by 828
Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible TuberculosisPayam Nahid, Andrew Vernon, Susan E. Dorman et al.|Clinical Infectious Diseases|2016Cited by 321
Moxifloxacin versus Ethambutol in the First 2 Months of Treatment for Pulmonary TuberculosisWilliam J. Burman, Richard E. Chaisson, Stefan Goldberg et al.|American Journal of Respiratory and Critical Care Medicine|2006Cited by 285